PaulE.HannaMD
Nephrology • Milwaukee, WIClinical and Research Fellow in Nephrology, BWH/MGH Joint Fellowship Program
Dr. Hanna is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9200 W Wisconsin Ave
Milwaukee, WI 53226Phone+1 414-805-3100Fax+1 262-532-9584
Summary
- Paul Hanna, MD, is a Boston-based Nephrologist who is a graduate from the Medical College of Wisconsin in 2017 and completed his Nephrology Fellowship at Brigham and Women's Hospital/Massachusetts General Hospital in 2020. He has contributed to the field with several publications. Notably, his work appears in Nephrology, Dialysis, Transplantation, Kidney International Reports, NPJ Breast Cancer, and JAMA Network Open, demonstrating extensive research in areas such as kidney function, kidney outcomes, and medication-related adverse events in patients with cancer.
Education & Training
Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 2020
Medical College of WisconsinClass of 2017
Certifications & Licensure
WI State Medical License 2019 - 2025
MA State Medical License 2020 - 2024- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 1 citationsSarcopenia, adiposity and large discordance between cystatin C and creatinine-based estimated glomerular filtration rate in patients with cancer.Paul E Hanna, Tianqi Ouyang, Ismail Tahir, Nurit Katz-Agranov, Qiyu Wang
Journal of Cachexia, Sarcopenia and Muscle. 2024-06-01 - 1 citationsRisk Factors for Severe Hypertension and Proteinuria After Treatment With Vascular Endothelial Growth Factor Signaling Pathway Inhibitors Among Patients With Cancer.Paul E Hanna, Rajesh K Anumolu, Shveta S Motwani, Kevin L Chen, Nurit Katz-Agranov
Kidney International Reports. 2024-06-01 - Acute and chronic kidney function decline in patients receiving BRAF/MEK inhibitors for melanoma.Kavita Mistry, Sophia Zhao, Ian Strohbehn, Qiyu Wang, Paul Hanna
Nephrology, Dialysis, Transplantation. 2024-05-31
Press Mentions
A Risk for Adverse Events in Cancer Meds Cleared RenallyJuly 19th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
